BP Meds and Falls; Gaseous Emboli From Pulsed Field Ablation; Stent Paper Retracted

In primary care, a first prescription for high blood pressure (BP) could be tied to a small increased risk of hospitalization or death due to a fall, according to a retrospective observational analysis. (Lancet Primary Care)

Maternal diabetes during pregnancy was linked with higher risks of cardiovascular disease in offspring, a cohort study found. (JAMA Cardiology)

Over 160 people in Northern Ireland were told that they got unnecessary cardiac resynchronization therapy devices from one cardiologist. (BBC News)

Instead of going to the emergency department, low-risk patients with acute atrial fibrillation could be treated with video-telehealth and specialized clinics, a pilot study suggested. (Heart)

To reduce gaseous emboli from pulsed field ablation, special attention to catheter advancement through the sheath may be required. (Heart Rhythm)

Scientists identified salvage-1 as a first-in-class therapeutic candidate for cardiac arrhythmias. (European Heart Journal)

Monitoring exhaled end-tidal carbon dioxide may help guide resuscitation for out-of-hospital cardiac arrest. (Circulation)

Untrained novices could reliably identify left ventricular dysfunction thanks to artificial intelligence-assisted cardiac ultrasound, a prospective study showed. (European Heart Journal-Digital Health)

SGLT2 inhibitor use was tied to better clinical outcomes after transcatheter aortic valve replacement in a propensity-matched analysis. (Structural Heart)

Meanwhile, early SGLT2 inhibitor use after Takotsubo syndrome was associated with lower all-cause mortality, but not lower cardiovascular event rates, in a real-world cohort study. (American Journal of Cardiology)

Ivabradine and propranolol performed about the same in postural orthostatic tachycardia syndrome, a small placebo-controlled crossover trial found, though the former produced a larger jump in upright systolic blood pressure. (Journal of the American College of Cardiology)

In the first inclisiran (Leqvio) trial in patients with recent acute coronary syndrome, the PCSK9-targeting RNA therapy still produced substantial LDL cholesterol lowering. (Journal of the American Heart Association)

Innate immune cell crosstalk is implicated in driving cardiac allograft vasculopathy after heart transplantation, indicating a potential therapeutic target. (Nature Cardiovascular Research)

A 2017 study on stents with microengineered grooves was only recently retracted due to issues with undisclosed author conflicts and one unreported death in the study. (Retraction Watch)

Cardiologists are not keen on there being any heart benefits to eating beef tallow. (TODAY)